Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$139.01

-8.99 (-6.07%)

20:10
04/20/17
04/20
20:10
04/20/17
20:10

Tesaro CEO responds to Zejula pricing questions, Endpoints News says

Tesaro CEO Lonnie Moulder has responded to questions surrounding the company's pricing of Zejula, saying that "if you read the FDA approved labeling you will see that 69% of patients are down-dosed, which means 31% continue on the 300mg daily starting dose and approximately 70% of the patients will receive either 200mg with a [Wholesale Acquisition Cost] of $9,833 or 100mg with a WAC of $4,917," reports Endpoints News, citing an email from Moulder. According to the report, the CEO added, "The down dosing occurs over the first 1-3 months which is not uncommon for oral anticancer agents as the physician 'dials in' the dose. The median dose and the most common dose were 200mg. Zejula is supplied as a 100mg capsule which means a patient takes either 1 or 2 or 3 capsules once daily based upon what they are prescribed." Reference Link

  • 30

    Jun

TSRO Tesaro
$139.01

-8.99 (-6.07%)

04/20/17
COWN
04/20/17
NO CHANGE
COWN
Tesaro launch of Zejula reduces likelihood of a takeout, says Cowen
Cowen analyst Boris Peaker said Tesaro's launch of Zejula yesterday significantly reduces the likelihood of an "imminent" acquisition. The analyst believes the launch will be a disappointment for some investors that were holding the stock with an expectation for an imminent takeout. As previously discussed, Peaker did not expect a takeout at this stage given potentially significant competitor risk from Clovis's (CLVS) ARIEL3 trial expected to report results this summer. The analyst rates Tesaro a Market Perform with a $145 price target.
04/20/17
RHCO
04/20/17
NO CHANGE
RHCO
Tesaro has no negative read through from AbbVie failure, says SunTrust
SunTrust analyst Peter Lawson says that there is "no impact" on Tesaro's (TSRO) niraparib from the failure of AbbVie's (ABBV) PARP inhibitor, veliparib, in triple negative breast cancer and lung cancer. The analyst believes that niraparib could be more effective than veliparib. Additionally, he notes that during its trial veliparib was used in combination with chemotherapy, while niraparib will be combined with Merck's (MRK) Keytruda for its trial. He thinks that the pairing with Keytruda will result in more effective treatment. The analyst keeps a $235 price target and a Buy rating on Tesaro.
04/20/17
LEER
04/20/17
NO CHANGE
Target $158
LEER
Market Perform
Tesaro price target lowered to $158 from $186 at Leerink
Leerink analyst Seamus Fernandez lowered his price target for Tesaro (TSRO) to $158 from $186 on valuation. The analyst notes that the company announced the availability and launch of Zejula as well as pricing of $14,750/month, a 7% premium to Clovis' (CLVS) Rubraca, but he estimates an average pricing of $10,350/month given the frequency of dose reductions. Fernandez reiterates a Market Perform rating on the shares pending the results of TOPACIO and ARIEL3.
04/20/17
SBSH
04/20/17
NO CHANGE
Target $216
SBSH
Buy
Tesaro price target lowered to $216 from $232 at Citi
Citi analyst Robyn Karnauskas lowered her price target for Tesaro to $216 to reflect the pricing of Zejula. After speaking to management, the analyst expects the net price to be around $9,000, lower than her $10,000 estimate. The price, however, could position the company well for a good launch and future competition, Karnauskas tells investors in a research note. She keeps a Buy rating on Tesaro.

TODAY'S FREE FLY STORIES

16:39
06/23/17
06/23
16:39
06/23/17
16:39
General news
Moody's raises Greece rating to Caa2 from Caa3, outlook to positive from stable »

Moody's has upgraded…

CFCO

CF Corporation

$11.42

-0.04 (-0.35%)

16:38
06/23/17
06/23
16:38
06/23/17
16:38
Hot Stocks
Breaking Hot Stocks news story on CF Corporation »

Mason Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$6.65

0.35 (5.56%)

, X

U.S. Steel

$22.25

1.18 (5.60%)

16:34
06/23/17
06/23
16:34
06/23/17
16:34
General news
On The Fly: Top stock stories for Friday »

Stocks opened in quiet…

AKS

AK Steel

$6.65

0.35 (5.56%)

X

U.S. Steel

$22.25

1.18 (5.60%)

PTLA

Portola Pharmaceuticals

$56.13

17.88 (46.75%)

BAC

Bank of America

$22.82

-0.11 (-0.48%)

C

Citi

$63.41

-0.21 (-0.33%)

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

JPM

JPMorgan

$86.86

-0.16 (-0.18%)

MS

Morgan Stanley

$43.69

-0.92 (-2.06%)

WFC

Wells Fargo

$52.45

-0.04 (-0.08%)

SNCR

Synchronoss

$16.24

4.06 (33.33%)

BBBY

Bed Bath & Beyond

$29.65

-4.09 (-12.12%)

BBRY

BlackBerry

$9.71

-1.35 (-12.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 23

    Jun

  • 24

    Jun

  • 26

    Jun

  • 29

    Jun

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 25

    Jul

  • 25

    Jul

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 15

    Jan

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

FMC

FMC Corporation

$74.78

0.52 (0.70%)

16:31
06/23/17
06/23
16:31
06/23/17
16:31
Hot Stocks
FMC Corporation to sell Omega-3 business to Pelagia AS, terms not disclosed »

FMC Corporation has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/23/17
06/23
16:30
06/23/17
16:30
Options
Preliminary option volume of 15.0M today »

Preliminary option volume…

ESNC

EnSync

$0.33

0.0151 (4.79%)

16:25
06/23/17
06/23
16:25
06/23/17
16:25
Syndicate
Breaking Syndicate news story on EnSync »

EnSync files $25M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

PTLA

Portola Pharmaceuticals

$56.13

17.88 (46.75%)

16:25
06/23/17
06/23
16:25
06/23/17
16:25
Conference/Events
Portola Pharmaceuticals hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 24

    Jun

DTE

DTE Energy

$108.89

-0.69 (-0.63%)

16:24
06/23/17
06/23
16:24
06/23/17
16:24
Earnings
DTE Energy backs FY17 operating EPS view $5.15-$5.46, consensus $5.33 »

DTE Energy will meet with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

$NSD

NASDAQ Market Internals

16:17
06/23/17
06/23
16:17
06/23/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VHI

Valhi Inc

$3.29

0.14 (4.44%)

16:16
06/23/17
06/23
16:16
06/23/17
16:16
Hot Stocks
Valhi Inc termiantes purchase deal for sale of Waste Control Specialists »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
06/23/17
06/23
16:16
06/23/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBL

GAMCO Investors

$29.63

-0.24 (-0.80%)

, LSXMA

Liberty SiriusXM

$40.83

0.79 (1.97%)

16:14
06/23/17
06/23
16:14
06/23/17
16:14
Hot Stocks
Breaking Hot Stocks news story on GAMCO Investors, Liberty SiriusXM »

Gabelli reports 5.22%…

GBL

GAMCO Investors

$29.63

-0.24 (-0.80%)

LSXMA

Liberty SiriusXM

$40.83

0.79 (1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WETF

WisdomTree

$9.98

-0.11 (-1.09%)

16:13
06/23/17
06/23
16:13
06/23/17
16:13
Hot Stocks
WisdomTree to close, liquidate three ETFs »

WisdomTree announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONN

Conn's

$17.10

0.15 (0.88%)

16:11
06/23/17
06/23
16:11
06/23/17
16:11
Hot Stocks
Breaking Hot Stocks news story on Conn's »

Point72 Asset reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$74.87

-0.655 (-0.87%)

, WFM

Whole Foods

$42.95

-0.255 (-0.59%)

16:11
06/23/17
06/23
16:11
06/23/17
16:11
Periodicals
Wal-Mart not weighing offer for Whole Foods, Reuters reports »

Wal-Mart (WMT) is not…

WMT

Wal-Mart

$74.87

-0.655 (-0.87%)

WFM

Whole Foods

$42.95

-0.255 (-0.59%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

APDN

Applied DNA Sciences

$1.09

0.06 (5.83%)

16:10
06/23/17
06/23
16:10
06/23/17
16:10
Hot Stocks
Applied DNA Sciences receives order to tag 27.5M pounds of cotton »

Applied DNA Sciences is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOCO

Mocon

16:08
06/23/17
06/23
16:08
06/23/17
16:08
Hot Stocks
Gabelli liquidates stake in Mocon »

As a result of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKTDY

Takata

$3.15

1.2199 (63.21%)

16:03
06/23/17
06/23
16:03
06/23/17
16:03
Periodicals
Takata to seek bankruptcy protection as soon as Sunday, WSJ reports »

Takata intends to seek…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIPT

Tiptree Financial

16:02
06/23/17
06/23
16:02
06/23/17
16:02
Hot Stocks
Tiptree Financial repurchases 1M shares from Nomura Securities »

Tiptree has repurchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFBC

Preferred Bank

16:01
06/23/17
06/23
16:01
06/23/17
16:01
Hot Stocks
Preferred Bank raises quarterly dividend 11% to 20c per share »

Preferred Bank reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

16:01
06/23/17
06/23
16:01
06/23/17
16:01
Hot Stocks
Amgen receives positive CHMP opinion to expand use of Mimpara »

Amgen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 19

    Jul

  • 14

    Aug

  • 03

    Feb

WFM

Whole Foods

$43.20

-0.06 (-0.14%)

, WMT

Wal-Mart

$74.66

-0.86 (-1.14%)

15:56
06/23/17
06/23
15:56
06/23/17
15:56
Periodicals
Wal-Mart not considering bid for Whole Foods, Reuters says 

Reuters cites a source.

WFM

Whole Foods

$43.20

-0.06 (-0.14%)

WMT

Wal-Mart

$74.66

-0.86 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$7.77

-0.03 (-0.38%)

, FTI

TechnipFMC

$26.69

-0.045 (-0.17%)

15:30
06/23/17
06/23
15:30
06/23/17
15:30
Periodicals
Petrobras seeks to change riser contract with TechnipFMC, Reuters reports »

Petrobras (PBR) is in…

PBR

Petrobras

$7.77

-0.03 (-0.38%)

FTI

TechnipFMC

$26.69

-0.045 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

EZPW

EZCORP

$9.00

0.25 (2.86%)

15:22
06/23/17
06/23
15:22
06/23/17
15:22
Hot Stocks
Breaking Hot Stocks news story on EZCORP »

Rovida Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$140.55

0.57 (0.41%)

, RUT

Russell 2000 Index

15:22
06/23/17
06/23
15:22
06/23/17
15:22
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$140.55

0.57 (0.41%)

RUT

Russell 2000 Index

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.